Importance of fatty acid substituents of chemically synthesized lipid A-subunit analogs in the expression of immunopharmacological activity.
about
Characterization of WRSs2 and WRSs3, new second-generation virG(icsA)-based Shigella sonnei vaccine candidates with the potential for reduced reactogenicity.Enhancement of immunoglobulin G responses in mice against hepatitis B virus surface antigen, influenza virus hemagglutinin vaccine, and tetanus toxoid by 6-O-acylated muramyl dipeptidesImmunopharmacological activities of 2-keto-3-deoxyoctonic acid-(alpha 2----6)-linked 4-O-phosphono-D-glucosamine derivatives carrying N- and 3-O-acyl substituentsMacrophage activation by an ornithine-containing lipid or a serine-containing lipidStructural characterization of the lipid A component of Helicobacter pylori rough- and smooth-form lipopolysaccharidesBurkholderia mallei expresses a unique lipopolysaccharide mixture that is a potent activator of human Toll-like receptor 4 complexes.Molecular adjuvants and immunomodulators: new approaches to immunization.SDZ MRL 953, a novel immunostimulatory monosaccharidic lipid A analog with an improved therapeutic window in experimental sepsis.Low biological activity of Helicobacter pylori lipopolysaccharide.Inflammasome-mediated secretion of IL-1β in human monocytes through TLR2 activation; modulation by dietary fatty acids.Activity of monosaccharide lipid A analogues in human monocytic cells as agonists or antagonists of bacterial lipopolysaccharide.Relationship of structure and biological activity of monosaccharide lipid A analogues to induction of nitric oxide production by murine macrophage RAW264.7 cellsDT-5461, a new synthetic lipid A analogue, inhibits lung and liver metastasis of tumor in mice.Induction of tumor necrosis factor in mice by recombinant human macrophage colony-stimulating factor.
P2860
Q34394744-4D7F5369-0FF1-4E7C-AF46-6D58EBA9CCA7Q35097345-0DA58309-CF71-4E70-A728-E06E3F868EFAQ35097378-E54EBFF8-61D1-4D21-BAB9-4341C028458BQ35111482-1D234BEE-4951-457F-9646-415A6C1703F7Q35631473-843F1A79-1F75-4EC7-B0AD-2AAD34FE27D7Q35987326-2347E93E-87E3-4766-B4D1-83F5D0C2F8C8Q36641572-AC369800-14A5-47EF-8827-6F0776000C47Q36753101-4B6DA0C8-C102-4D40-BF4B-494764E95303Q36944099-E206E509-5672-4EFF-8888-330B51E04CEBQ37302656-639420C2-B0C8-46E0-9016-1060AAF1EA10Q39513148-D7A37523-8038-423F-9DFB-56CD70D54591Q39573960-81415E4F-545A-4324-9206-F85F61AF6CCAQ55077610-C7C7E42E-A34B-449E-B0EF-6F2EE8F51FF9Q55082275-B352F1E9-9807-4E2B-BA21-D5EE17422725
P2860
Importance of fatty acid substituents of chemically synthesized lipid A-subunit analogs in the expression of immunopharmacological activity.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
Importance of fatty acid subst ...... mmunopharmacological activity.
@en
type
label
Importance of fatty acid subst ...... mmunopharmacological activity.
@en
prefLabel
Importance of fatty acid subst ...... mmunopharmacological activity.
@en
P2093
P2860
P1476
Importance of fatty acid subst ...... mmunopharmacological activity.
@en
P2093
Kumazawa Y
Nakatsuka M
Takimoto H
Yamamoto A
P2860
P304
P407
P577
1988-01-01T00:00:00Z